{
    "nctId": "NCT05505643",
    "briefTitle": "Cryoablation vs Lumpectomy in T1 Breast Cancers",
    "officialTitle": "COOL-IT: Cryoablation vs Lumpectomy in T1 Breast Cancers: A Randomized Controlled Trial With Safety Lead-in",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Breast Neoplasm",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 256,
    "primaryOutcomeMeasure": "Safety Lead-In: Number of treatment-related complications",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of invasive ductal carcinoma of the breast of Luminal type A (ER/PR positive, Her-2 negative) that is grade 1 or 2 with intraductal component \\<25%. Must be T1N0M0 (2 cm or less).\n* Oncotyping will be performed on T1b+Allred\\<6/8 and T1c tumors. Oncotype score in this subset of patients must be \\<26 to be included in the trial.\n* At least 50 years of age.\n* Mass must be visible on ultrasound and \\>5 mm from skin and chest wall muscles.\n* Able to understand and willing to sign an IRB-approved written informed consent document.\n\nExclusion Criteria:\n\n* Indication for neoadjuvant chemotherapy.\n* Presence of BRCA 1 and/or BRCA 2 mutation.\n* Prior history of breast cancer.\n* Breast augmentation.\n* Allergy to local anesthetics.\n* Pregnant or lactating. Women of childbearing potential must have a negative pregnancy test within 14 days of study entry.\n* DCIS present beyond the proposed ablation zone on MRI, mammography, or ultrasound.\n* Positive axillary lymph nodes as assessed by axillary ultrasound, axillary sampling, or axillary sentinel node procedure.",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}